rs111687884
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000138.5(FBN1):c.643C>T(p.Arg215*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R215R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000138.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Marfan syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- Acromicric dysplasiaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- progeroid and marfanoid aspect-lipodystrophy syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- stiff skin syndromeInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Weill-Marchesani syndrome 2, dominantInheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- geleophysic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated ectopia lentisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal Marfan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Weill-Marchesani syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ectopia lentis 1, isolated, autosomal dominantInheritance: AD Classification: LIMITED Submitted by: G2P
- Shprintzen-Goldberg syndromeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| FBN1 | NM_000138.5 | c.643C>T | p.Arg215* | stop_gained | Exon 7 of 66 | ENST00000316623.10 | NP_000129.3 | |
| FBN1 | NM_001406716.1 | c.643C>T | p.Arg215* | stop_gained | Exon 6 of 65 | NP_001393645.1 | ||
| FBN1 | NM_001406717.1 | c.643C>T | p.Arg215* | stop_gained | Exon 7 of 9 | NP_001393646.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| FBN1 | ENST00000316623.10 | c.643C>T | p.Arg215* | stop_gained | Exon 7 of 66 | 1 | NM_000138.5 | ENSP00000325527.5 | ||
| FBN1 | ENST00000559133.6 | n.643C>T | non_coding_transcript_exon_variant | Exon 7 of 67 | 1 | ENSP00000453958.2 | ||||
| FBN1 | ENST00000674301.2 | n.643C>T | non_coding_transcript_exon_variant | Exon 7 of 68 | ENSP00000501333.2 | |||||
| FBN1 | ENST00000537463.6 | n.636+7C>T | splice_region_variant, intron_variant | Intron 7 of 30 | 5 | ENSP00000440294.2 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 32 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Marfan syndrome    Pathogenic:3 
The Arg215X variant has been reported in the literature in one individual with c linical features of Marfan syndrome (Matsukawa 2001). This variant leads to a pr emature stop codon at position 215, which is predicted to lead to a truncated or absent protein. Therefore, this variant is highly likely to be pathogenic. -
The c.643C>T;p.(Arg215*) variant creates a premature translational stop signal in the FBN1 gene. It is expected to result in an absent or disrupted protein product - PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 42401; PMID: 11139245; 16220557; 17657824; 27611364; 32431097) - PS4. This variant is not present in population databases (rs111687884, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. In summary, the currently available evidence indicates that the variant is pathogenic. -
- -
not provided    Pathogenic:3 
Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 11139245, 31098894, 29357934, 32431097, 17657824, 19293843, 27234404, 27611364, 16220557, AgaogluNB2022, 15241795) -
- -
- -
not specified    Pathogenic:1 
- -
Familial thoracic aortic aneurysm and aortic dissection    Pathogenic:1 
The p.R215* pathogenic mutation (also known as c.643C>T), located in coding exon 6 of the FBN1 gene, results from a C to T substitution at nucleotide position 643. This changes the amino acid from an arginine to a stop codon within coding exon 6. This variant was reported in individual(s) with features consistent with Marfan syndrome (Matsukawa R et al. Hum Mutat. 2001;17(1):71-2). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Progeroid and marfanoid aspect-lipodystrophy syndrome    Pathogenic:1 
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2. -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection    Pathogenic:1 
This sequence change creates a premature translational stop signal (p.Arg215*) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Marfan syndrome (PMID: 11139245, 16220557, 17657824, 27611364). ClinVar contains an entry for this variant (Variation ID: 42401). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at